Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Multicenter Study in First-line Treatment of Advanced progredIeNT Follicular And Other IndoleNt and Mantle Cell Lymphomas

NCT00877214 is registered in ClinicalTrials.gov with Jurgen Barth as lead sponsor.

NCT NCT00877214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00877214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Multicenter Study in First-line Treatment of Advanced progredIeNT Follicular And Other IndoleNt and Mantle Cell Lymphomas
Lead sponsor
Jurgen Barth
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 1, 2009
Completion date
December 31, 2024
Enrollment
1,272 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphomas, immunocytomas, lymphocytic lymphoma, mantle-cell lymphomas, marginal zone lymphomas, non-hodgkin's lymphoma